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Abstract
Background: Interaction between immune system and Chandipura virus (CHPV) during different stages of its life
cycle remain poorly understood. The exact route of virus entry into the blood and CNS invasion has not been
clearly defined. The present study was undertaken to assess the population in PBMC that supports the growth of
virus and to detect active virus replication in PBMC as well as its subsets.
Methods: PBMC subsets viz.: CD3+, CD14+, CD19+, CD56+cells were separated and infected with CHPV. The infected
cells were then assessed for transcription (N gene primer) and replication (NP gene primer) of CHPV by PCR. The
supernatant collected from infected cells were titrated in Baby Hamster Kidney (BHK) cells to assess virus release.
The cytokine and chemokine expression was quantified by flow cytometry.
Results: Amplification of N and NP gene was detected in CD14+ (monocyte) and CD19+ (B cell), significant increase
in virus titre was also observed in these subsets. It was observed that, although the levels of IL-6 and IL-10 were
elevated in CD14+ cells as compared to CD19+cells, the differences were not significant. However the levels of
TNFα and IL-8 were significantly elevated in CD14+ cells than in CD19+cells. The levels of chemokine (CXCL9, CCL5,
CCL2, CXCL10) were significantly elevated in CHPV infected PBMC as compared to uninfected cells. CCL2 and
CXCL9 were significantly increased in CHPV infected CD14+cells as compared to CD19+ cells.
Conclusion: CD14+and CD19+cells support active replication of CHPV. High viral load was detected in CD14+ cells
infected with CHPV hence it might be the primary target cells for active replication of CHPV. An elevated levels of
cytokines and chemokines observed in CD14+ cells may help in predicting the pathogenecity of CHPV and possible
entry into the central nervous system.
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Background
Chandipura virus (CHPV) belongs to family Rhabdoviridae,
genus Vesiculovirus. The family consists of several import-
ant human, animal and plant pathogens like rabies virus,
vesicular stomatitis virus (VSV), potato yellow dwarf virus
and Isfahan virus, etc. It is bullet shaped and consists of a
linear, single stranded negative sense RNA molecule of ap-
proximately 11,120 base pairs [1, 2]. CHPV was first isolated
from the serum of a patient with febrile illness in Chandi-
pura village near Nagpur, Maharashtra in India during an in-
vestigation of Chikungunya outbreak [3, 4]. CHPV was
incriminated as the etiological agent of large-scale encephal-
itis outbreaks in children with high case fatality rate in
various districts of Andhra Pradesh, Gujarat and Maharash-
tra indicating its disease causing potential [4, 5].
Viruses belonging to the Vesiculovirus genera share
similar genomic and structural organization [6, 7]. The
molecular regulations of their replication and transcrip-
tion events are also comparable. The five transcriptional
units are transcribed by a single promoter at the 3′end
and code for the nucleocapsid protein (N), phospho-
protein (P), matrix protein (M), glycoprotein (G) and
polymerase large protein (L). The RNA genome is tightly
encapsidated by the viral N protein to form helical
ribonucleoprotein complex (RNP). This encapsidated
genome serves as template for both replication and
transcription. One of the molecules that have been
implicated in the trasnscription-replication switch is the
viral N protein. The intracellular concentration of N* Correspondence: gajanansapkalniv@gmail.com
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protein modulates the transition of polymerase action
from transcription to replication by encapsidating the
nascent leader RNA and thereby suppressing the inter-
genic transcription termination signals. In VSV, it was
suggested that N-P complex formation could be the key
mechanism for this switch. Infected cell extract immu-
nodepleted of N-P complex with an antibody against P
protein was unable to support replication in an in vitro
assay. All these reports strongly suggest a possible
auxiliary function of P protein in viral replication [8–11].
Recently it has been shown that P protein undergoes
considerable structural changes upon Leader (Le) RNA
binding thus forming functional replicase complex L-N-P-
Le-RNA [12].
Sandfly (Phlebotomus papatasi) acts as a vector for
CHPV transmission which has been confirmed in murine
model experimentally [13]. The studies in the murine
model reveal that blood cells are attractive targets for
CHPV as they are located mainly in the circulation and
causes acute inflammation followed by dissemination into
the central nervous system [14, 15]. CHPV was isolated
from patient’s leukocytes suggest that blood leukocytes
could be infected and involved in viral production [4]. The
exact route of entry to the susceptible cells in the central
nervous system (CNS) and the events taking place during
the acute blood phase of CHPV infections has not been
clearly understood. Interactions between immune system
during CHPV life cycle remains poorly defined. Although
the role of cytokine and chemokine is unclear, increased
levels of certain cytokines has been observed in CHPV
related encephalopathy in children [16]. However the inter-
action of peripheral blood mononuclear cells (PBMC) and
its subsets with CHPV is unclear. In this study we tried to
understand the susceptibility of PBMC and its subtypes to
CHPV infection. We have also assessed cytokine and
chemokine levels from the infected cell population which
could give us the insight of CHPV pathogenesis.
Methods
Cell line and virus
Baby hamster kidney (BHK) cell line was maintained in
Minimal essential medium (MEM, Sigma) with 10 % fetal
calf serum (FCS; Gibco). Chandipura virus (CHPV) used
in this study was (CIN6514) isolated in 1965 [3]. The viral
stock was prepared in BHK cells and stored at −80 °C for
further use. The inactivated CHPV was prepared by UV
treatment. Briefly tissue cultured grown CHPV virus was
exposed to UV for 40 min. The virus infectivity was con-
firmed with three blind passages in BHK cells. Titration of
the virus stock was carried in BHK cells by plaque assay.
The virus titre was determined as plaque forming
units per milliliter (pfu/ml) or Tissue culture infective
dose 50(TCID50/ml) to calculate multiplicity of infec-
tion (MOI) in infection experiments [17].
PBMC isolation and cell separation
Buffy coat packs from adult healthy anonymous donors
(N = 9) were obtained from a hospital blood bank, (Pune,
India). Since the informed consent was obtained from
voluntary blood donors at the time of blood donation,
the institutional human ethical committee, (National
Institute of Virology, Institutional human ethics commit-
tee) confirmed that no further approval is required for
using anonymized leftover specimens/components from
blood donations of the local blood bank for scientific
purposes. The samples were tested for presence of anti-
CHPV antibodies before use. PBMCs were isolated by
Ficoll Hypaque (Sigma, USA) gradient centrifugation
and resuspended in RPMI 1640 medium with 10 % FCS.
Magnetic Activated Cells Sorting (MACS) [Miltenyi Bio-
tec, Inc. Auburn, CA] was used for separation of CD3+
(T lymphocytes), CD14+ (Monocytes) and CD19+ (B
lymphocytes), CD56+ (NK cells) cells from whole PBMC
as per manufacturer’s guidelines [18].
Determination of cell purity
Various cell population viz. CD3+, CD14+, CD19+, CD56+
were sorted using MACS and re-suspended in PBS.
Specific phycoerythrin (PE) conjugated monoclonal anti-
bodies were added to each subset and incubated at 4 °C
for 30 min. The cells were washed and fixed with 1 %
paraformaldehyde in PBS and were analyzed using Cell
Quest Pro software in FACS-calibur (BD Bioscience,
USA). The percentage purity of isolated cells was found to
be in the range 95 to >96 %.
In vitro infection and quantification
The PBMC and CD3+, CD14+, CD19+, CD56+ cells
were infected with CHPV in complete medium (RPMI +
10 % FCS). Briefly, 0.2 x 106 to 1x106 PBMC and its
subsets were infected with viral suspension for 1 h at 37 °
C, in 5 % CO2. The cells were washed thrice with PBS,
and replenished with complete medium. Uninfected cell
controls as well as cells infected with UV inactivated virus
were also treated in similar way. Cell culture supernatant
and cell lysates were collected at defined time points to
determine virus growth kinetics and cytokine levels. The
virus titre in the culture supernatant was estimated.
Briefly, serial tenfold virus dilutions prepared in MEM
with 2 % FBS was added in triplicate to the BHK cells.
The plate was incubated at 37°C with 5 % CO2, and
observed daily for cytopathic effect. After 72 h, the assay
was terminated and stained with 1 % amido black. The
virus titers were expressed as TCID50/ml) [17].
Detection of CHPV transcriptive and replicative
intermediate
CHPV infected PBMC, CD3+, CD14+, CD19+, CD56+
and mock controls were harvested at different time
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intervals post infection. CD19+cells were treated with
0.01 % of sodium azide and infected with CHPV to
analyze for replicative intermediate for ruling out the
possibility of the uptake of CHPV was not due to
capping of immunoglobulin. RNA was extracted from
cell lysate by using TRIzol® RNA extraction method (Life
Technologies) as per manufactures instruction. One step
Reverse transcriptase polymerase chain reaction (RT-
PCR) was performed using kit containing 2X PCR mix
and SuperScript® III Reverse transcriptase/Platinum®Taq
DNA polymerase (Invitrogen CA, USA). One microgram
of total RNA was subjected to one step RT-PCR with
different primer pairs corresponding to the following:
i) upstream (5’-CGG AGA GAA ATG TTG TTG
TGT G-3’) and downstream (5’-GCA AAG AGT TTC
CTG GCG TA-3’) primers specific for a 150 bps ampli-
con of the N gene, used for transcription assessment.
For replication assessment ii) upstream (5’-TGG AAA
GGG TAG GAG ATA TTC GA-3’) and downstream (5’-
GAG AGT GTC CTG AAG CTT TGG-3’) primers spe-
cific for a 150 bps amplicon of the N-P gene junction
specific primers were used [12]. The RT-PCR products
were resolved on 1.8 % agarose gel and visualized by
staining with ethidium bromide.
Determination of pro-inflammatory cytokine and
chemokine levels
Pro-inflammatory cytokine and chemokine concentration
in the CHPV infected and mock infected culture super-
natant and un-infected cell supernatant control were de-
termined using a cytometric bead array (CBA) kit (BD,
Biosciences, USA) on a FACS Calibur with appropriate
controls. The acquired data was analyzed using FCAP
array 2.0 software and each sample was tested in triplicate.
Statistical analysis
Wilcoxon signed-rank test was used to determine modu-
lations in chemokine levels. Paired test was applied to
compare cytokine and chemokine levels among CHPV
infected PBMC, CD14+cell, CD19+cell supernatant and
respective uninfected cell control (CC). Differences with
p ≤ 0.05 were considered statistically significant.
Results
PBMC support active replication of CHPV RNA
During CHPV life cycle, N gene is the earliest gene tran-
scribed after viral entry. Whereas during virus replication
phase tripartite complex (N-P-L) is synthesized and could
be detected by N-P junction primers. Detection of N-P
gene thus assures that signature transcription termination
sequence (characteristic of all Rhabdoviruses) is ignored
and viral replication is initiated. Therefore, the detection
of N gene and NP gene could be used as an index to de-
termine transcription and replication respectively.
In order to investigate whether PBMC supports the
active CHPV replication, PBMC from the nine healthy
donors were infected with CHPV at different MOI
(MOI = 1, 2 and 5). Cell pellets were harvested at various
time intervals and analyzed for replicative and transcrip-
tive intermediates of CHPV using N gene (replicative)
and NP gene (transcriptive) primers by one step RT-
PCR. There was no amplification of N and NP gene was
observed when infected with MOI = 1 and MOI = 2.
Whereas 150 bp amplicon was detected for N gene
(transcription) at 2 h post infection (pi) with MOI = 5 of
CHPV. While NP gene (replication) was detected at 4 h
pi onwards when infected with MOI = 5 CHPV (Fig. 1).
To determine the extent of replication in PBMC, the
culture supernatants collected at various time intervals
were analyzed for CHPV replication kinetics. There was
no increase in the virus titer with MOI = 1 and 2
whereas with MOI = 5 there was a gradual increase in
virus titre at 12 h pi, it increased up to 2 log TCID50 and
reached its peak up to 7 log TCID50 after 24 h pi. At
48 h pi, the virus titre declined to 4 log TCID50 (Fig. 2).
CHPV target cell(s) support CHPV replication
To determine which subsets of PBMC supports the CHPV
replication, CD3+, CD14+, CD19+and CD56+cells were
separated from PBMC and each were infected with MOI
= 5 of CHPV. The N gene and NP gene was not amplified
in CD3+cells and CD56+cells. Analysis of CD14+ and
CD19+ cells revealed N gene and NP gene amplification
corresponding to band size of 150 bp indicating that
CD14+and CD19+ cells support CHPV replication. There
was no amplification of N gene and NP gene observed in
cell subsets infected with UV inactivated CHPV. Overall
these results indicate that CD3+cells and CD56+cells did
not support active replication while CD14+ cells as well as
CD19+support CHPV growth (Fig. 3).
Comparative analysis of CHPV replication in CD14+ and
CD19+ cells
Since the replicative intermediates were detected in both
CD14+ (monocyte) cells and CD19+ (B cells) comparative
viral replication kinetics were assessed for infectious virion
release from these subsets. The release of virus from CD3
+cells, CD56+cells was lower and remained at the basal
level throughout the study indicated that these cell subsets
did not support active replication of CHPV. Whereas
there was a gradual increase in virus titre that peaked at
24 h pi up to 5 log TCID50 in CD14
+ cells which was
found to be higher than CD19+ cells with 3 log TCID50.
At 48 h pi the virus replication declined (Fig. 4).
Pro inflammatory cytokine and chemokine analysis
Levels of pro-inflammatory cytokine (IL-1β, IL-6, IL-8,
IL-10, and TNFα) were found to be elevated and
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significantly higher among infected PBMC as compared to
their respective controls. Levels of IL-6, IL-10,IL-8 and
TNFα were found to be significantly increased in CD19
+cell (B cells) as compared to its controls (p < 0.005). There
was no significant difference in IL-1β levels from CHPV
infected B cells and its control. IL-6, IL-8, IL-10 and TNFα
levels were found to be significantly increased in CD14
+cells (monocytes) as compared to its controls (p < 0.005)
(Fig. 5a, b). The difference in IL-1β levels in CHPV
infected CD14+cells and its controls were not significant.
Although the levels of IL-6 and IL-10 were elevated in
CD14+ cells as compared to CD19+cells, the differences
were not significant. However the levels of TNFα and IL-8
were significantly elevated in CD14+ cells than in CD19
+cells (p < 0.005). The levels of chemokine (CXCL9, CCL5,
CCL2, CXCL10) were significantly elevated in CHPV
infected PBMC as compared to uninfected cells. CCL2
and CXCL9 were significantly increased in CHPV infected
CD14+cells as compared to CD19+ cells (Fig. 5c).
Discussion
These studies were initiated to determine the contribu-
tion of PBMC subsets to CHPV amplification and cyto-
kine secretion in triggering the innate immune response.
Fig. 1 Detection of transcriptive and replicative form of CHPV in human PBMC. The PBMC’s were isolated from the whole blood cells of healthy
donors and infected with MOI = 5 CHPV in complete medium (RPMI + 10 % FCS). Cells were harvested at different hours time interval (1, 2, 3 , 8,
12 and 24 h) and total RNA was extracted by Trizol method. The transcriptive form (N gene) and replicative form (NP gene) was detected by RT-
PCR. The assay was performed in triplicates
Fig. 2 Replication kinetics of CHPV in human PBMC. The PBMC’s from healthy donors were infected with CHPV at MOI = 1, MOI = 2 and MOI = 5
along with the controls. The culture supernatant was collected at different time interval (0, 12, 24 and 48 h) post infection. The release of progeny
virus was quantitated by calculating TCID50 titre in BHK cells
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There are no animal models that mimic the clinical syn-
drome of severe encephalitis in humans and therefore
observational studies of patient cohorts are the main
source of understanding immunopathogenesis of CHPV
infection [5, 16]. Limited studies in mice revealed that
CHPV induces viremia followed by dissemination of the
virus to secondary infection sites and reach the CNS.
During peripheral circulation, blood leukocytes such as
monocytes, dendritic cells and natural killer (NK) cells
are the main components of innate immunity and they
have been implicated in the immunopathogenesis of
many viral diseases. These cells are attractive virus
targets because they are located mainly in the circulation
and peripheral tissues moreover they can assist virus dis-
semination [14, 15].
Our result demonstrates that CHPV replicate in
monocytes as well as in B cells and trigger cytokine re-
sponse. In vitro model of unfractionated PBMC infected
with CHPV indicated lodging of virus. Although the
intracellular positive staining for CHPV was observed,
very low numbers of cells were infected even at high
viral load (MOI = 10) and hence no significant conclu-
sions could be drawn (flow cytometry, data not shown).
In order to assess the replication in infected cells, the
virus release and the replicative intermediates were ana-
lyzed. Consistent to earlier report by A. Roy et al. [12],
the transcriptive intermediate (N gene) was detected
after 2 h pi and replicative intermediate (NP gene) were
detected after 4 h pi in PBMC infected with CHPV. It
has been proposed that during CHPV transcription, pro-
gressive termination at each gene junction produce the
positive sense leader RNA and 5′mRNA corresponding
to 5 viral genes that are N, P, M, G and L [2, 7]. The
detection of N gene amplification indicated the positive
strand RNA genome i.e., transcription in the infected
cells. During replication, the gene junction termination
signals are ignored to produce positive strand polycis-
tronic RNA complementary to the whole genome which
then serves as the template for the synthesis of progeny
genome RNA [2, 7, 12]. Data represented here further
revealed the NP gene amplification which is the replica-
tion template present only during virus replication, was
found in infected cells. To determine the extent of
replication in PBMC, infectious virus titres were deter-
mined using supernatants collected at various time
Fig. 3 Detection of transcriptive and replicative form of CHPV in human PBMC subsets. The PBMC was isolated from the whole blood cells healthy
donors. CD3+,CD14+,CD19+ cells were separated from PBMCs by MACS separation method and were infected with CHPV at MOI = 5 in complete
medium (RPMI + 10 % FCS). Cells were harvested at 24 h pi and total RNA was separated by Trizol method. The transcriptive form (N gene) and
replicative form (NP gene) was detected by RT-PCR. The assay was performed in triplicates. Cell control is represented as C in the figure
Fig. 4 Replication kinetics of CHPV in human PBMC subsets ( )
PBMC, ( ) CD14+cells, ( ) CD19+cells and ( ) CD3+cells
infected with MOI = 5 of CHPV. The culture supernatant was
collected at different time interval. The release of progeny virus was
quantitated by calculating TCID50 titre in BHK cells. The assay was
performed in triplicates
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points post infection. It was observed that the amount of
virus detected in infected cells increased over time. The
titre peaked at 24 h pi which confirms that PBMC
support CHPV replication.
We further extended our studies to pinpoint the target
cell(s) of CHPV infection in PBMC. PBMC consist of
roughly 70 % T cells, 10 % B cells, 10 % Monocytes and
1 % NK cells [19]. The CD3+ (T cells), CD14+ (Mono-
cytes), CD19+ (B cells), CD56+ (NKcells) were infected
with MOI = 5 of CHPV. Monocyte and B cell support
active replication of CHPV. The replication of CHPV
observed in monocytes or B cells was not due to the
contamination of either cell as subsets used for studies
contained high percentage of monocyte/B cell. Infected
cells coexpressed the cell markers (CD14/CD19) and
viral antigens. One of our key findings is that primary
monocyte without stimulation or differentiation was
permissive for CHPV replication. The titres of virus re-
leased from the infected monocytes (5 log TCID50) were
found significantly higher than B cells (3 log TCID50). It
was reported that B cell line (Raji) adapted dengue virus
could replicate in B lymphocytes in in vitro infection
model [20, 21]. The CHPV used in the current study
was not grown /adapted in any B cell and monocyte cell
line or PBMC. Cells treated with sodium azide exhibited
the presence of both N and NP gene amplification. Thus
the efficiency of infection probably reflects viral entry
receptors expressed on these cells that requires further
studies. Studies on other members of Rhabdoviridae
family such as VSV and rabies virus demonstrated that
monocytes support replication of these viruses. It was
also reported that rabies virus infects murine macro-
phages (IC-21 and bone marrow derived macrophages)
as well as human macrophage cell (U937 and THP-1)
in-vitro [19, 22–24]. Several studies on arboviral model
suggested that blood leukocyte such as monocytes and B
cells support viral growth. Chikungunya virus actively
replicates in monocytes whereas in dengue virus, mono-
cytes are the primary cells among PBMC, while B lympho-
cytes also harbours and supports dengue virus infection
[17, 20, 21, 25]. Overall we observed that monocytes and
B cells are permissible for CHPV growth. The experimen-
tal conditions used thus reflect more closely the environ-
ment where these subsets may encounter in vivo virus
Fig. 5 Cytokine and Chemokine levels in CHPV infected human PBMC subsets. a Pro-inflammatory cytokine levels (IL-10, IL-8) in CHPV infected
PBMC, CD14+cell, CD19+cell supernatant. b Pro-inflammatory cytokine levels (TNFα, IL-6, IL-1β) in CHPV infected PBMC, CD14+cell, CD19+cell
supernatant and respective un infected cell control (CC) at 24 h post infection (pi). c Chemokine levels (CCL2, CCL5, CXCL9, CXCL10) in CHPV
infected PBMC, CD14+cell, CD19+cell supernatant and respective un infected cell control (CC) at 24 h post infection. The box plot represents
minimum, first quartile, median, third quartile and maximum. Total of 9 donors were used in the experiment. Statistical analysis was performed by
Wilcoxon signed rank test. Paired test was applied to compare cytokine and chemokine levels among CHPV infected PBMC, CD14+cell, CD19+cell
supernatant and respective uninfected cell control (CC). p value < 0.05 (*) significant, (**) 0.005 moderately significant and (***) 0.0005 highly
significant among groups
Roy et al. BMC Infectious Diseases  (2016) 16:487 Page 6 of 8
infection. The modulation of the cytokine and chemokine
responses during the course of CHPV has not been fully
elucidated. It has been shown that during early infection
(within 24 h) there is pro- and anti-inflammatory response
to CHPV infection in vitro; however, the dynamics of
cytokine and chemokine response during the course of
CHPV replication in human is unknown. We further
investigated the ability of purified monocyte/ B cells to
trigger the cytokine and chemokine response after CHPV
infection. Elevated levels of IL-1β, IL-6, IL-8, IL-10 and
TNFα were observed in CHPV infected PBMC as
compared to their mock controls. IL-6, IL-10, TNFα
levels were significantly higher in monocytes as com-
pared to B cells.
The elevated levels of IL-6, IL-10, and TNFα have been
suggested to play a role in the pathogenicity of CHPV in
mice model [14]. In addition similar observations were
made in patients with CHPV encephalitis [14, 16, 26].
These results corroborate our findings that CHPV replica-
tion favors the induction of pro-inflammatory response.
CHPV infection of PBMC, Monocytes and B cells
strongly stimulated the chemokines (CCL2/MCP-1,
CCL5/rantes, CXCL9, CXCL10/IP10) during the course
of infection. Elevated levels of CCL2, CCL5, CXCL9, and
CXCL10 were observed in infected monocytes and B
cells as compared to their controls. However, the se-
creted levels of CCL2 and CXCL9 were significantly
higher in monocytes as compared to B cell. Although
the role of chemokines in CHPV infection is unclear, the
increased levels of CCL2 during CHPV infection in mice
model might play a role in increasing the permeability of
blood brain barrier (BBB) to allow virus into CNS
[14, 15]. Increased level of CCL2 might also explain
the accumulation of lymphocytes and macrophages in
the spleen, lymph nodes and other tissue [27].
Various studies found upregulation of CCL2, CCL3,
CCL5, CXCL9, and CXCL10 in CNS after rabies virus
infection suggested being responsible for the increased
infiltration of inflammatory cells and BBB permeability
[28, 29]. Moreover it was also reported that CCL2 is
responsible for increased permeability and transmigra-
tion of HIV infected human leukocytes across BBB in in
vitro model [30]. Here the up regulations of CCL2 and
CXCL9 in CHPV infected monocytes were observed.
Changes in cytokine and chemokine levels during the
course of CHPV infection could have a major impact on
the immune system; influencing pathogenesis by enhan-
cing or suppressing CHPV replication as well as favour-
ing the formation of infected cell reservoirs in CNS
needs to be determined.
Conclusion
From this study we concluded that monocytes and B
cells support active replication of CHPV, high viral load
was detected in monocytes infected with CHPV. The
elevated levels of IL-10, IL-6, IL-8, TNFα (cytokines) and
CCL2 and CXCL9 (chemokines) in monocytes may help
in predicting the pathogenicity of CHPV causing en-
cephalitis and possible entry into the central nervous
system. This was the first reported data of the cytokine
and chemokine profile of CHPV.
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